U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H15NOS2
Molecular Weight 337.459
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of IMB-10

SMILES

CC1=CC=CC=C1N2C(=S)S\C(=C/C=C/C3=CC=CC=C3)C2=O

InChI

InChIKey=UYZLENPCNZVWQZ-DNZSEPECSA-N
InChI=1S/C19H15NOS2/c1-14-8-5-6-12-16(14)20-18(21)17(23-19(20)22)13-7-11-15-9-3-2-4-10-15/h2-13H,1H3/b11-7+,17-13-

HIDE SMILES / InChI

Molecular Formula C19H15NOS2
Molecular Weight 337.459
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 2
Optical Activity NONE

IMB-10 stabilizes binding of alpha(M)beta(2) to its endogenous ligands proMMP-9 and fibrinogen. It inhibited alpha(M)beta(2)-dependent migration in vitro and inflammation-induced neutrophil emigration in vivo. IMB-10 therapy inhibited the growth of both leukemia and lymphoma xenografts and significantly prolonged the survival of the mice with lymphoma. IMB-10 has potential as a therapy for leukocytic malignancies, particularly for lymphomas.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.4 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Stabilization of the activated alphaMbeta2 integrin by a small molecule inhibits leukocyte migration and recruitment.
2006 Mar 7
A simple, no-wash cell adhesion-based high-throughput assay for the discovery of small-molecule regulators of the integrin CD11b/CD18.
2007 Apr
Identification of novel agonists of the integrin CD11b/CD18.
2009 Dec 15
Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease.
2011 Sep 6
Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion.
2013 Jul 5
Patents

Patents

Sample Use Guides

Mice: 4 ug
Route of Administration: Intravenous
On a fibrinogen matrix, IMB-10 completely inhibited migration of THP-1 and OCI-AML-3 cells at a 25 µM concentration.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:30:25 GMT 2023
Edited
by admin
on Sat Dec 16 08:30:25 GMT 2023
Record UNII
9DDO6X234Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IMB-10
Common Name English
4-THIAZOLIDINONE, 3-(2-METHYLPHENYL)-5-(3-PHENYL-2-PROPENYLIDENE)-2-THIOXO-
Systematic Name English
4-THIAZOLIDINONE, 3-(2-METHYLPHENYL)-5-(3-PHENYL-2-PROPEN-1-YLIDENE)-2-THIOXO-
Systematic Name English
Code System Code Type Description
CAS
307525-40-2
Created by admin on Sat Dec 16 08:30:25 GMT 2023 , Edited by admin on Sat Dec 16 08:30:25 GMT 2023
PRIMARY
EPA CompTox
DTXSID40184777
Created by admin on Sat Dec 16 08:30:25 GMT 2023 , Edited by admin on Sat Dec 16 08:30:25 GMT 2023
PRIMARY
PUBCHEM
1555648
Created by admin on Sat Dec 16 08:30:25 GMT 2023 , Edited by admin on Sat Dec 16 08:30:25 GMT 2023
PRIMARY
FDA UNII
9DDO6X234Z
Created by admin on Sat Dec 16 08:30:25 GMT 2023 , Edited by admin on Sat Dec 16 08:30:25 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY